White AC Jr. Cryptosporidiosis (Cryptosporidium species). Bennett JE, Dolin R, Blaser MK, eds. Principles and Practice of Infectious Diseases. Philadelphia, Pa: Elsevier Inc; 2020. 3410-3420.
Checkley W, White AC Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2015 Jan. 15 (1):85-94. [QxMD MEDLINE Link].
Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013 Jan. 26(1):115-34. [QxMD MEDLINE Link]. [Full Text].
Khalil IA, Troeger C, Rao PC, et al. Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health. 2018 Jul. 6 (7):e758-e768. [QxMD MEDLINE Link].
Korpe PS, Valencia C, Haque R, et al. Epidemiology and Risk Factors for Cryptosporidiosis in Children From 8 Low-income Sites: Results From the MAL-ED Study. Clin Infect Dis. 2018 Nov 13. 67 (11):1660-1669. [QxMD MEDLINE Link].
Tomczak E, McDougal AN, White Jr AC. Resolution of Cryptosporidiosis in Transplant Recipients: Review of the Literature and Presentation of a Renal Transplant Patient Treated With Nitazoxanide, Azithromycin, and Rifaximin. Open Forum Infect Dis. 2022. 9:[QxMD MEDLINE Link].
Šlapeta J. DNA barcoding of Cryptosporidium. Parasitology. 2018 Apr. 145 (5):574-584. [QxMD MEDLINE Link].
Nader JL, Mathers TC, Ward BJ, Pachebat JA, Swain MT, Robinson G, et al. Evolutionary genomics of anthroponosis in Cryptosporidium. Nat Microbiol. 2019 May. 4 (5):826-836. [QxMD MEDLINE Link].
Gharpure R, Perez A, Miller AD, Wikswo ME, Silver R, Hlavsa MC. Cryptosporidiosis Outbreaks - United States, 2009-2017. MMWR Morb Mortal Wkly Rep. 2019 Jun 28. 68 (25):568-572. [QxMD MEDLINE Link].
Chalmers RM, Robinson G, Elwin K, Elson R. Analysis of the Cryptosporidium spp. and gp60 subtypes linked to human outbreaks of cryptosporidiosis in England and Wales, 2009 to 2017. Parasit Vectors. 2019 Mar 12. 12 (1):95. [QxMD MEDLINE Link].
Chalmers RM, Smith R, Elwin K, Clifton-Hadley FA, Giles M. Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales, 2004-2006. Epidemiol Infect. 2011 May. 139(5):700-12. [QxMD MEDLINE Link].
Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis. 1999 Oct. 180 (4):1275-81. [QxMD MEDLINE Link].
Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S, et al. Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg. 2006 Nov. 75 (5):851-7. [QxMD MEDLINE Link].
Garza A, Lackner A, Aye P, D'Souza M, Martin P Jr, Borda J, et al. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol. 2008 Jun. 37 (3):109-15. [QxMD MEDLINE Link].
Goodgame RW, Kimball K, Ou CN, White AC Jr, Genta RM, Lifschitz CH, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology. 1995 Apr. 108 (4):1075-82. [QxMD MEDLINE Link].
Kelly P, Makumbi FA, Carnaby S, Simjee AE, Farthing MJ. Variable distribution of Cryptosporidium parvum in the intestine of AIDS patients revealed by polymerase chain reaction. Eur J Gastroenterol Hepatol. 1998 Oct. 10 (10):855-8. [QxMD MEDLINE Link].
See AlsoHealth Care Provider Information on CryptosporidiosisParasites - Cryptosporidium (also known as "Crypto") | Cryptosporidium | ParasitesThe Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)Cryptosporidium - MN Dept. of HealthYoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol. 2010 Jan. 124(1):31-9. [QxMD MEDLINE Link].
Painter JE, Hlavsa MC, Collier SA, Xiao L, Yoder JS, Centers for Disease Control and Prevention. Cryptosporidiosis surveillance -- United States, 2011-2012. MMWR Suppl. 2015 May 1. 64 (3):1-14. [QxMD MEDLINE Link].
Bouzid M, Kintz E, Hunter PR. Risk factors for Cryptosporidium infection in low and middle income countries: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Jun. 12 (6):e0006553. [QxMD MEDLINE Link].
Painter JE, Gargano JW, Yoder JS, Collier SA, Hlavsa MC. Evolving epidemiology of reported cryptosporidiosis cases in the United States, 1995-2012. Epidemiol Infect. 2016 Jun. 144 (8):1792-802. [QxMD MEDLINE Link].
Centers for Disease Control and Prevention. Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables. CDC. Available at https://wonder.cdc.gov/nndss/nndss_annual_tables_menu.asp. Accessed: November 6, 2019.
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis. 2011 Jan. 17(1):7-15. [QxMD MEDLINE Link]. [Full Text].
Mac Kenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med. 1994 Jul 21. 331(3):161-7. [QxMD MEDLINE Link].
Hlavsa MC, Cikesh BL, Roberts VA, Kahler AM, Vigar M, Hilborn ED, et al. Outbreaks Associated with Treated Recreational Water - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018 May 18. 67 (19):547-551. [QxMD MEDLINE Link].
Vandenberg O, Robberecht F, Dauby N, Moens C, Talabani H, Dupont E, et al. Management of a Cryptosporidium hominis outbreak in a day-care center. Pediatr Infect Dis J. 2012 Jan. 31 (1):10-5. [QxMD MEDLINE Link].
Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010 Jun 19. 24 (10):1549-59. [QxMD MEDLINE Link].
sem*nza JC, Nichols G. Cryptosporidiosis surveillance and water-borne outbreaks in Europe. Euro Surveill. 2007 May 1. 12(5):E13-4. [QxMD MEDLINE Link].
Sow SO, Muhsen K, Nasrin D, et al. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2016 May. 10 (5):e0004729. [QxMD MEDLINE Link].
Platts-Mills JA, Liu J, Rogawski ET, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018 Dec. 6 (12):e1309-e1318. [QxMD MEDLINE Link].
Wang RJ, Li JQ, Chen YC, Zhang LX, Xiao LH. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy. Acta Trop. 2018 Nov. 187:257-263. [QxMD MEDLINE Link].
Ajjampur SS, Rajendran P, Ramani S, Banerjee I, Monica B, Sankaran P, et al. Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. J Med Microbiol. 2008 Nov. 57:1364-8. [QxMD MEDLINE Link].
Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug. 79(2):210-4. [QxMD MEDLINE Link]. [Full Text].
Wanyiri JW, Kanyi H, Maina S, Wang DE, Steen A, Ngugi P, et al. Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses. Am J Trop Med Hyg. 2014 Aug. 91 (2):319-28. [QxMD MEDLINE Link].
Wang ZD, Liu Q, Liu HH, Li S, Zhang L, Zhao YK, et al. Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasit Vectors. 2018 Jan 9. 11 (1):28. [QxMD MEDLINE Link].
Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg. 1999 Nov. 61(5):707-13. [QxMD MEDLINE Link].
Sponseller JK, Griffiths JK, Tzipori S. The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation. Clin Microbiol Rev. 2014 Jul. 27 (3):575-86. [QxMD MEDLINE Link].
Naseer M, Dailey FE, Juboori AA, Samiullah S, Tahan V. Epidemiology, determinants, and management of AIDS cholangiopathy: A review. World J Gastroenterol. 2018 Feb 21. 24 (7):767-774. [QxMD MEDLINE Link].
Lanternier F, Amazzough K, Favennec L, Mamzer-Bruneel MF, Abdoul H, Tourret J, et al. Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study. Transplantation. 2017 Apr. 101 (4):826-830. [QxMD MEDLINE Link].
Hashmey R, Smith NH, Cron S, Graviss EA, Chappell CL, White AC Jr. Cryptosporidiosis in Houston, Texas. A report of 95 cases. Medicine (Baltimore). 1997 Mar. 76 (2):118-39. [QxMD MEDLINE Link].
Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002 Nov 2. 360(9343):1375-80. [QxMD MEDLINE Link].
Adler S, Widerström M, Lindh J, Lilja M. Symptoms and risk factors of Cryptosporidium hominis infection in children: data from a large waterborne outbreak in Sweden. Parasitol Res. 2017 Oct. 116 (10):2613-2618. [QxMD MEDLINE Link].
Korpe PS, Haque R, Gilchrist C, Valencia C, Niu F, Lu M, et al. Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition. PLoS Negl Trop Dis. 2016 May. 10 (5):e0004564. [QxMD MEDLINE Link].
O'connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS. 2011 Mar 13. 25(5):549-60. [QxMD MEDLINE Link].
Garcia LS, Arrowood M, Kokoskin E, Paltridge GP, Pillai DR, Procop GW, et al. Laboratory Diagnosis of Parasites from the Gastrointestinal Tract. Clin Microbiol Rev. 2018 Jan. 31 (1):[QxMD MEDLINE Link].
Khurana S, Chaudhary P. Laboratory diagnosis of cryptosporidiosis. Trop Parasitol. 2018 Jan-Jun. 8 (1):2-7. [QxMD MEDLINE Link].
Robinson G, Chalmers RM. Cryptosporidium Diagnostic Assays: Microscopy. Methods Mol Biol. 2020. 2052:1-10. [QxMD MEDLINE Link].
Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J Med Microbiol. 2011 Nov. 60:1598-604. [QxMD MEDLINE Link].
Freeman K, Mistry H, Tsertsvadze A, Royle P, McCarthy N, Taylor-Phillips S, et al. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis. Health Technol Assess. 2017 Apr. 21 (23):1-188. [QxMD MEDLINE Link].
Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002 Jan. 15(1):145-54. [QxMD MEDLINE Link]. [Full Text].
Reynoso D, White Jr C. Nitazoxanide. Grayson M, ed. Kucers' The Use of Antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. Boca Raton: Taylor and Francis Group; 2017. 3162-74.
Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. 2006 Mar. 4(3):320-4. [QxMD MEDLINE Link].
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001 Jul 1. 184 (1):103-6. [QxMD MEDLINE Link].
Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998 Sep. 178(3):900-3. [QxMD MEDLINE Link].
Rossignol JF. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients. Aliment Pharmacol Ther. 2006 Sep 1. 24 (5):887-94. [QxMD MEDLINE Link].
Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009 Dec 2. 9:195. [QxMD MEDLINE Link]. [Full Text].
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. AIDSinfo. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed: November 6, 2019.
Centers for Disease Control and Prevention. DPDx - Laboratory Identification of Parasites of Public Health Concern: Cryptosporidiosis. CDC. Available at https://www.cdc.gov/dpdx/cryptosporidiosis/index.html. Accessed: November 6, 2019.
Bhadauria D, Goel A, Kaul A, Sharma RK, Gupta A, Ruhela V, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015 Feb. 17 (1):48-55. [QxMD MEDLINE Link].
Chavez MA, White AC Jr. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther. 2018 Aug. 16 (8):655-661. [QxMD MEDLINE Link].
Nachipo P, Hermann D, Quinnan G, Gordon MA, Van Voorhis WC, Iroh Tam PY. Evaluating the safety, tolerability, pharmaco*kinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial. Trials. 2018 Aug 23. 19 (1):456. [QxMD MEDLINE Link].
Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, et al. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis. 2017 Feb. 11 (2):e0005373. [QxMD MEDLINE Link].
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001 Jul 1. 184(1):103-6. [QxMD MEDLINE Link].
Stiff RE, Davies AP, Mason BW, Hutchings HA, Chalmers RM. Long-term health effects after resolution of acute Cryptosporidium parvum infection: a 1-year follow-up of outbreak-associated cases. J Med Microbiol. 2017 Nov. 66 (11):1607-1611. [QxMD MEDLINE Link].
FAQs
What is the antiparasitic medication for Cryptosporidium? ›
Nitazoxanide oral suspension (100 mg/5ml; patients ≥ 1 year of age) and Nitazoxanide tablets (500 mg; patients ≥ 12 years of age) are indicated for the treatment of diarrhea caused by Cryptosporidium.
What antiparasitic drugs are used for diarrhea? ›Metronidazole (Flagyl)
Very active against Giardia species, gram-negative anaerobes, and Entamoeba species. Imidazole ring-based antibiotic active against various anaerobic bacteria and protozoa. Often used in combination with other antimicrobial agents except for C difficile enterocolitis).
We can't get rid of the crypto infection. However, there are ways to control the diarrhea it causes. These include Imodium, Kaopectate, Pepto-Bismol (bismuth subsalicylate), tincture of opium, and similar preparations. If you have diarrhea, it is important to drink plenty of fluids to avoid becoming dehydrated.
What is the agent of cryptosporidiosis? ›Causative Agent: Cryptosporidiosis is a parasitic infection caused by Cryptosporidium parvum. Route of Exposure: Fecal-oral, which includes person to person, animal to person, waterborne, and foodborne transmission.
How long does it take to get rid of Cryptosporidium? ›How long does it last? In healthy people, symptoms usually last about 2 weeks. The symptoms may go in cycles in which you seem to get better for a few days, then feel worse, before the illness ends. Most healthy people do not need any specific treatment and will recover on their own.
Will cryptosporidiosis go away on its own? ›Most people with a healthy immune system don't need to be treated. Cryptosporidiosis will resolve on its own. In those who have a weak immune system, the focus of treatment is often on getting the immunity back. Otherwise, a medicine called nitazoxanide can be used to treat this parasite.
What is the strongest medicine for diarrhea? ›For acute diarrhea, over-the-counter medications such as loperamide and bismuth subsalicylate tend to be the first drug choice. In other instances, prescription medications such as alosetron, eluxadoline, and rifaximin may be recommended.
What is the miracle drug for diarrhea? ›IMODIUM® A-D Anti-Diarrheal Softgels with Loperamide HCl is an OTC medicine for diarrhea that aims to relieve diarrhea symptoms and helps bring your digestion back to its natural rhythm.
What is the best medicine to get rid of diarrhea? ›- Loperamide (Imodium) slows the movement of food through your intestines, which lets your body absorb more liquid.
- Bismuth subsalicylate (Kaopectate, Pepto-Bismol) balances out how fluid moves through your digestive tract.
Unexplained digestive problems, itchiness, anemia, muscular and joint pain, and inability to feel satisfied after even a hearty meal are some of the commonly experienced signs you may have a parasite. Call your doctor if your unusual signs indicate the presence of a parasite.
How to get rid of Cryptosporidium naturally? ›
- Drink plenty of fluids to remain well hydrated and avoid dehydration. ...
- Maintain a well-balanced diet. ...
- Avoid beverages that contain caffeine, such as tea, coffee, and many soft drinks.
- Avoid alcohol, as it can lead to dehydration.
Some parasitic infections disappear on their own, especially if your immune system is healthy and you eat a balanced diet. For parasites that don't go away on their own, your doctor will generally prescribe oral medication. This treatment is generally effective and proven to work.
What does giardia poop look like? ›Symptoms include explosive, watery, greasy, foul-smelling stools, bloating, nausea, pain, gas, fatigue, and loss of appetite. Several medicines are available that cure the infection.
How to treat parasites in humans? ›Antiparasitic drugs are a group of medications used in the management and treatment of infections by parasites, including protozoa, helminths, and ectoparasites. Antiparasitic drugs include several classes of drugs that cover a broad range of diseases caused by parasites.
When to go to the hospital for parasites? ›Indications include: – Persistent and severe symptoms. If you have a high fever, severe diarrhea, vomiting, abdominal pain, bloating, and cramping, it may be a sign of a severe parasitic infection that requires immediate medical attention.
Can ivermectin cure Cryptosporidium? ›Ivermectin is used worldwide against a broad range of endoparasites (nematodes) and ectoparasites (acarine, insects) of humans and animals. Moreover, a number of studies have shown activity of the drug against protozoan parasites such as Giardia lamblia, Cryptosporidium spp.
What kills Cryptosporidium and giardia? ›Look for a filter that has a pore size of 1 micron or less. This will remove microbes 1 micron or greater in diameter (Cryptosporidium, Giardia).
Does metronidazole treat Cryptosporidium? ›While not effective against Cryptosporidium, nitroimidazoles such as metronidazole or tinidazole are effective treatments for giardiasis and can be administered as a single dose. Albendazole and nitazoxanide are effective against giardiasis but require multiple doses.
What parasites does nitazoxanide treat? ›In humans, nitazoxanide is effective against a broad range of parasites, including Giardia, Entamoeba, Cryptosporidium, Cyclospora, Trichom*onas, Encephalitozoon intestinalis, Isospora belli, Blastocystis hominis, Balantidium coli, Ascaris, Trichuris trichura, Taenia saginata, Hymenolepis nana, and Fasciola hepatica [1, ...